Immunoprecise Antibodies Ltd Working Capital to Net Assets Ratio

Latest as of April 2025: 41.2%

Immunoprecise Antibodies Ltd working capital to net assets ratio. Immunoprecise Antibodies Ltd (IPA) has a Working Capital to Net Assets ratio of 41.2% as of April 2025. Working capital of $9.74 Million (current assets of $18.75 Million minus current liabilities of $9.01 Million) is measured against net assets of $23.63 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.

WC/NA Ratio

41.2%
Working Capital / Net Assets

Working Capital

$9.74 Million
USD

Current Assets

$18.75 Million
USD

Current Liabilities

$9.01 Million
USD

Working Capital to Net Assets Ratio of Immunoprecise Antibodies Ltd (1997–2025)

Working capital to net assets ratio of Immunoprecise Antibodies Ltd from 1997 to 2025. This chart shows how Immunoprecise Antibodies Ltd's Working Capital to Net Assets ratio has evolved across 29 annual periods from 1997 to 2025. As of April 2025, the ratio stands at 41.2%, reflecting working capital of $9.74 Million against net assets of $23.63 Million USD. Explore Immunoprecise Antibodies Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Immunoprecise Antibodies Ltd Working Capital to Net Assets Ratio by Year (1997–2025)

Immunoprecise Antibodies Ltd working capital to net assets ratio by year from 1997 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Immunoprecise Antibodies Ltd from 1997 to 2025, covering 29 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IPA total asset value.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 41.2% $9.74 Million $23.63 Million $18.75 Million $9.01 Million ▲ +31.3 pp
2024 9.9% $3.36 Million $33.92 Million $11.49 Million $8.12 Million ▼ -8.9 pp
2023 18.8% $10.87 Million $57.80 Million $16.79 Million $5.92 Million ▼ -18.7 pp
2022 37.5% $28.21 Million $75.28 Million $37.47 Million $9.26 Million ▼ -37.7 pp
2021 75.2% $42.79 Million $56.92 Million $48.86 Million $6.07 Million ▲ +76.7 pp
2020 -1.5% $-230.32K $15.09 Million $7.70 Million $7.93 Million ▼ -16.3 pp
2019 14.8% $2.67 Million $18.07 Million $9.88 Million $7.20 Million ▲ +10.9 pp
2018 3.9% $498.38K $12.70 Million $4.78 Million $4.28 Million ▼ -75.2 pp
2017 79.2% $2.45 Million $3.09 Million $3.28 Million $836.91K ▼ -12.5 pp
2016 91.6% $832.24K $908.26K $1.22 Million $385.52K ▼ -9.8 pp
2015 101.4% $-211.49K $-208.52K $43.16K $254.64K ▼ -1.1 pp
2014 102.5% $-165.21K $-161.21K $138.29K $303.50K ▼ 0.0 pp
2013 102.5% $-221.09K $-215.66K $44.54K $265.63K ▼ -3.1 pp
2012 105.6% $-126.58K $-119.89K $86.52K $213.10K ▲ +10.2 pp
2011 95.4% $151.16K $158.40K $261.36K $110.21K ▲ +94.5 pp
2010 0.9% $49.39K $5.43 Million $147.26K $97.87K ▼ -7.8 pp
2009 8.7% $592.44K $6.78 Million $743.28K $150.84K ▼ -0.2 pp
2008 9.0% $459.26K $5.12 Million $496.72K $37.46K ▲ +8.1 pp
2007 0.9% $49.67K $5.43 Million $463.36K $413.69K ▼ -13.1 pp
2006 14.0% $546.25K $3.91 Million $684.87K $138.62K ▼ -45.7 pp
2005 59.7% $2.52 Million $4.23 Million $2.57 Million $47.18K ▲ +15.0 pp
2004 44.6% $622.27K $1.39 Million $672.19K $49.92K ▲ +42.8 pp
2003 1.9% $16.15K $867.54K $45.69K $29.53K ▲ +21.8 pp
2002 -19.9% $-137.94K $691.56K $49.78K $187.72K ▲ +187.9 pp
2001 -207.8% $-544.93K $262.24K $351.82K $896.75K ▼ -280.7 pp
2000 72.9% $288.92K $396.53K $299.03K $10.11K ▲ +43.6 pp
1999 29.2% $473.78K $1.62 Million $509.56K $35.78K ▼ -7.2 pp
1998 36.4% $1.04 Million $2.86 Million $1.11 Million $66.92K ▼ -28.4 pp
1997 64.8% $2.35 Million $3.63 Million $2.60 Million $250.04K —
pp = percentage points